CompletedNCT00602381
Bioequivalency Study of 450 mg Lithium Carbonate Under Fasting Conditions
Medication studyAges 25–45United StatesBipolarity
Understand this study
Who was this study for?
Listed age limits: 25 years to 45 years.
- Listed locations
- Little RockSee all locations and recruitment
Study information
Study start dateNovember 2002
- Recruitment status
- Completed
- Enrollment listed in the registry
- 30
- Sponsor
- Roxane Laboratories
- Sponsor type
- Pharmaceutical company
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 25 Years to 45 Years
- Official registry ID
- NCT00602381
- Official title
Show the full official title
A Single Dose, Three-Treatment, Three-Period, Six-Sequence Crossover Bioequivalency Study of 450 mg Lithium Carbonate Extended Release Tablets Under Fasting Conditions
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Little Rock
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Roxane Laboratories, a pharmaceutical company.
Did this study involve medication?
Yes. The study involved medication, including lithium.
Who was this study for?
Listed age limits: 25 years to 45 years.
